Trial intelligence / Profile preview

Pyrotinib plus capecitabine versus placebo plus capecitabine in HER2-positive metastatic breast cancer

CTR20160442Phase 3Active

Sponsor

Hengrui Therapeutics

Start

Jul 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1